
Sources: AI synthetic research startup Aaru raised a Series A at a $1B ‘headline’ valuation
Aaru raises a Series A with a $1B headline valuation using multi-tier terms. The AI startup simulates human behaviour for enterprise and political research.
36 articles · page 2 of 3 · showing 13 to 24

Aaru raises a Series A with a $1B headline valuation using multi-tier terms. The AI startup simulates human behaviour for enterprise and political research.

Bending Spoons, the Milan-based tech giant behind Evernote, WeTransfer, and Vimeo deals, has acquired Eventbrite for $500M. Learn its strategy, value, and plans.

Kara Nortman and Jasmine Robinson’s $250 million Monarch Collective has expanded from U.S. women’s soccer into European football and WNBA ownership. The investment firm focuses on building…

Google and Accel team up to invest up to $2M per startup, supporting India’s AI innovators with funding, mentorship, cloud credits, and access to Gemini and DeepMind models.

Investors are buying “venture zombies”—stalled VC-backed startups—and reviving them with a hold-forever strategy, generating profits without selling, as demonstrated by Bending Spoons and…

Discover the groundbreaking technologies and visionary founders featured at the final StrictlyVC 2025 event in Palo Alto. From next-gen semiconductor breakthroughs to brain-computer…

Curastory founder Tiffany Kelly has resigned following an SEC settlement over alleged revenue misstatements, and Dave Dickman has been appointed as the company’s new CEO.

Shernaz Daver is leaving Khosla Ventures after reshaping the firm’s brand and elevating its position as a leading AI-focused VC. Her next move could signal what’s ahead for tech.

AI music startup Suno raises $250M at a $2.45B valuation, hitting $200M revenue as it faces major copyright lawsuits from global record labels.

Kaaj secures $3.8M to automate credit risk analysis, enabling lenders to process small-business loans in minutes rather than days with AI-powered workflows.

Onepot AI secures $13M to accelerate small-molecule synthesis with AI and automated labs, helping pharma companies develop drug compounds faster and more efficiently.

European startups and investors are stepping into politics, with Atomico’s latest report urging policy reforms as the tech sector seeks greater influence.